Thu, Dec 25, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

CTAs have faced a brave new world since 2008

Friday, November 16, 2012

By Beverly Chandler, Opalesque London:

The Opalesque Managed Futures Roundtable, sponsored by Efficient Capital Management, and Eurex heard that historically most CTAs find opportunity in markets that explode directionally.

Grant Jaffarian of Efficient Capital Management said: "As managed futures strategies evolve, they will not evolve beyond their ability to capture divergent opportunities and strong volatility trend moves. That will be the bread and butter. You will not hear CTAs say, "Let’s become a strategy that can only take advantage of less volatility, or perhaps strong mean reversion opportunities because long volatility trends and market shocks are a thing of the past." The trend-capture personality of managed futures is a good thing for long term returns and alpha contribution. When a well diversified portfolio needs CTAs, you want them to be there for the 2008 environment.".

Jaffarian added: "On the one hand, you do not want to switch everything you are doing, and I do not think the industry is doing that (we are certainly not, on that product). On the other hand, as a thoughtful manager and multi-manager allocator into managed futures, you need to be aware that this is not currently the ideal trend environm......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its